| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,877 | 16,591 | 16,161 | 15,922 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 16,591 | 16,161 | 15,922 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,671 | 18,838 | 12,699 | 18,803 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| (2,744) | 2,744 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,398) | 497 | 718 | (2,881) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 537 | (537) |
-
| | Earnings Before Interest And Taxes | (6,397) | 1,034 | 181 | (2,881) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (6,397) | 1,034 | 181 | (2,881) | | Income Tax Expense | (2,404) | 250 | (122) | (108) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,993) | 784 | 303 | (2,773) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,993) | 784 | 303 | (2,773) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,993) | $784 | $303 | ($2,773) |
|
1.52% Nasdaq 0.00%
Income Statement
